Literature DB >> 17229698

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Esther Larrea1, José I Riezu-Boj, Lucía Gil-Guerrero, Noelia Casares, Rafael Aldabe, Pablo Sarobe, María P Civeira, Jonathan L Heeney, Christine Rollier, Babs Verstrepen, Takaji Wakita, Francisco Borrás-Cuesta, Juan J Lasarte, Jesús Prieto.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan ratio (a reflection of IDO activity). Huh7 cells supporting hepatitis C virus (HCV) replication expressed higher levels of IDO mRNA than noninfected cells when stimulated with gamma interferon or when cocultured with activated T cells. In infected chimpanzees, hepatic IDO expression decreased in animals that cured the infection, while it remained high in those that progressed to chronicity. For both patients and chimpanzees, hepatic expression of IDO and CTLA-4 correlated directly. Induction of IDO may dampen T-cell reactivity to viral antigens in chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229698      PMCID: PMC1866047          DOI: 10.1128/JVI.02248-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Simultaneous measurement of serum tryptophan and kynurenine by HPLC.

Authors:  B Widner; E R Werner; H Schennach; H Wachter; D Fuchs
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

2.  Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

Authors:  J J Lasarte; M García-Granero; A López; N Casares; N García; M P Civeira; F Borrás-Cuesta; J Prieto
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

3.  The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Sylvaine You; Barbara C McGrath; Douglas R Cavener; Carmine Vacca; Ciriana Orabona; Roberta Bianchi; Maria L Belladonna; Claudia Volpi; Pere Santamaria; Maria C Fioretti; Paolo Puccetti
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  Prevention of allogeneic fetal rejection by tryptophan catabolism.

Authors:  D H Munn; M Zhou; J T Attwood; I Bondarev; S J Conway; B Marshall; C Brown; A L Mellor
Journal:  Science       Date:  1998-08-21       Impact factor: 47.728

5.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.

Authors:  H M Diepolder; R Zachoval; R M Hoffmann; E A Wierenga; T Santantonio; M C Jung; D Eichenlaub; G R Pape
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

6.  Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

Authors:  B Rehermann; K M Chang; J G McHutchison; R Kokka; M Houghton; F V Chisari
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 7.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

Review 8.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

9.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

10.  A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice.

Authors:  Ursula Grohmann; Francesca Fallarino; Roberta Bianchi; Ciriana Orabona; Carmine Vacca; Maria C Fioretti; Paolo Puccetti
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

View more
  51 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Experimental Periodontitis Results in Prediabetes and Metabolic Alterations in Brain, Liver and Heart: Global Untargeted Metabolomic Analyses.

Authors:  Vladimir Ilievski; Jason M Kinchen; Ramya Prabhu; Fadi Rim; Lara Leoni; Terry G Unterman; Keiko Watanabe
Journal:  J Oral Biol (Northborough)       Date:  2016-04-23

3.  Structural variants of IFNα preferentially promote antiviral functions.

Authors:  Nancy Vázquez; Hana Schmeisser; Michael A Dolan; Joseph Bekisz; Kathryn C Zoon; Sharon M Wahl
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 4.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

5.  Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells.

Authors:  M J Donovan; V Tripathi; M A Favila; N S Geraci; M C Lange; W Ballhorn; M A McDowell
Journal:  Parasite Immunol       Date:  2012-10       Impact factor: 2.280

6.  Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

Authors:  Jennifer M Loftis; Alexander L Patterson; Clare J Wilhelm; Henry McNett; Benjamin J Morasco; Marilyn Huckans; Timothy Morgan; Shira Saperstein; Aliya Asghar; Peter Hauser
Journal:  J Psychosom Res       Date:  2012-11-21       Impact factor: 3.006

7.  Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection.

Authors:  Koyo Higashitani; Tatsuya Kanto; Shoko Kuroda; Sachiyo Yoshio; Tokuhiro Matsubara; Naruyasu Kakita; Tsugiko Oze; Masanori Miyazaki; Mitsuru Sakakibara; Naoki Hiramatsu; Eiji Mita; Yasuharu Imai; Akinori Kasahara; Alato Okuno; Osamu Takikawa; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

8.  Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection.

Authors:  Julie M Fox; Leo K Sage; Spencer Poore; Scott Johnson; S Mark Tompkins; Ralph A Tripp
Journal:  J Leukoc Biol       Date:  2014-05-05       Impact factor: 4.962

Review 9.  A look behind closed doors: interaction of persistent viruses with dendritic cells.

Authors:  Mélanie Lambotin; Sukanya Raghuraman; Françoise Stoll-Keller; Thomas F Baumert; Heidi Barth
Journal:  Nat Rev Microbiol       Date:  2010-04-07       Impact factor: 60.633

Review 10.  Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?

Authors:  A Boasso; G M Shearer; C Chougnet
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.